Seek immediate medical attention, preferably at an emergency department. Priapism can cause permanent damage to penile tissue if not treated promptly.
Yes, but blood pressure should be monitored closely. Combining a PDE5 inhibitor with certain antihypertensives, especially alpha-blockers, may cause additive hypotensive effects.
Moderate alcohol intake is generally tolerated, but excessive drinking can increase dizziness and lower blood pressure, potentially heightening side-effects.
Udenafil has a longer duration of action (up to 12 hours) compared with sildenafil, which typically lasts 4-6 hours. Both share the same PDE5 inhibition mechanism but differ in pharmacokinetic profiles.
Zydena tablets are 100 mg, round, and imprinted with the brand name and dosage strength. Check the batch number, expiry date, and the MHRA-approved labeling on the blister pack.
Men with diabetes may benefit from PDE5 inhibitors, but they should have a cardiovascular assessment first, as diabetes increases the risk of vascular disease.
Yes. Although Zydena is not MHRA-authorized, it can only be supplied under a specialist’s prescription in accordance with UK law.
Keep the tablets in their original container at room temperature, away from heat and moisture. Avoid leaving them in a car trunk on hot days.
Standard workplace drug screens do not test for PDE5 inhibitors. However, specialized testing could detect the drug if specifically requested.
On average, onset of effect occurs within 30 minutes to 2 hours, depending on individual metabolism and whether the pill is taken with food.
Zydena is a branded medication that contains udenafil as its active component. It is supplied as a 100 mg oral pill and belongs to the therapeutic class of erectile dysfunction (ED) treatments. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) has not granted marketing authorization for Zydena, so it is considered an unlicensed product. Healthcare professionals may prescribe it only under a specialist’s direction and in compliance with UK prescribing regulations.
Udenafil is a selective phosphodiesterase-5 (PDE5) inhibitor. By blocking the PDE5 enzyme, it prevents the breakdown of cyclic guanosine monophosphate (cG gMP) in the smooth muscle cells of the penis. Elevated cG gMP leads to relaxation of these muscles, increased blood flow, and the erection needed for sexual activity. The drug is absorbed after oral ingestion, reaches peak plasma concentrations within 1-2 hours, and its effects typically last up to 12 hours. Metabolism occurs mainly via the hepatic CYP3A4 pathway.
Udenafil is approved for the treatment of erectile dysfunction in several Asian countries. In the UK, Zydena does not have an MHRA-approved indication, so its use is considered off-label and should be undertaken only with specialist supervision. The medication is intended for adult males who experience difficulty achieving or maintaining an erection sufficient for sexual activity.
Current peer-reviewed literature does not provide robust evidence for off-label uses of udenafil beyond erectile dysfunction. Consequently, no off-label applications are presented in this article.
Absolute contraindications
Relative contraindications
Special populations
If you fall into any of these categories, discuss alternative therapies with your prescriber.
Patients should provide a complete medication list, including over-the-counter products and herbal supplements, to their prescriber before starting Zydena.
Regular follow-up appointments allow the prescriber to assess efficacy, tolerability, and the need for dose adjustments.
This article provides educational information about Zydena and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
